Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3512204016 | Tenofovir alafenamide fumarate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3512205015 | Tenofovir alafenamide fumarate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 844211000172118 | fumarate de ténofovir alafénamide | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 844221000172111 | tenofoviralafenamidefumaraat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tenofovir alafenamide fumarate (substance) | Is a | Tenofovir alafenamide (substance) | false | Inferred relationship | Some | ||
| Tenofovir alafenamide fumarate (substance) | Has disposition (attribute) | Reverse transcriptase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Tenofovir alafenamide fumarate (substance) | Is modification of (attribute) | Tenofovir alafenamide (substance) | true | Inferred relationship | Some | ||
| Tenofovir alafenamide fumarate (substance) | Is a | Carboxylic ester (substance) | true | Inferred relationship | Some | ||
| Tenofovir alafenamide fumarate (substance) | Is a | Transferase inhibitor | false | Inferred relationship | Some | ||
| Tenofovir alafenamide fumarate (substance) | Is a | Reverse transcriptase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Tenofovir alafenamide fumarate (substance) | Inferred relationship | Some | 1 |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Tenofovir alafenamide fumarate (substance) | Inferred relationship | Some | 4 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR